Previous Close | 13.41 |
Open | 12.80 |
Bid | 13.34 x 0 |
Ask | 13.35 x 0 |
Day's Range | 13.29 - 13.50 |
52 Week Range | 9.05 - 16.57 |
Volume | |
Avg. Volume | 7,713,345 |
Market Cap | 2.76B |
Beta (5Y Monthly) | 0.49 |
PE Ratio (TTM) | 19.36 |
EPS (TTM) | 0.69 |
Earnings Date | N/A |
Forward Dividend & Yield | 0.11 (0.82%) |
Ex-Dividend Date | Jul 04, 2023 |
1y Target Est | N/A |
Geron (GERN) delivered earnings and revenue surprises of 10% and 102.67%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Geron Corporation (GERN) and Crinetics Pharmaceuticals (CRNX) gain on positive regulatory and study updates.